SMLE review course 2024 - Endocrine & ID - Dr.Abdulrahman Alahmadi

In the name of God, the Most Gracious, the Most Merciful. Peace, mercy, and blessings of God be upon you.

Welcome, everyone. I am Dr. Abdul Rahman Adnan Al-Ahmadi. Peace, mercy, and blessings of God be upon you. Welcome, everyone. I am Dr. Abdul Rahman Adnan Al-Ahmadi. God willing, today we will be

presenting or reviewing Endocrinology and AD. This review will be the last review for this year's course. Of course, it will be the same idea as the previous lectures. You will need to watch the videos from previous years in 2022 and 2023, and then watch today's lecture. The review for Endocrinology will focus on

Diabetes and Thyroid Diseases, which have the most new questions this year. There were only two new questions for Adrenal Diseases, so there aren't many updates. For the remaining questions, you will need to go back. Many people ask me if I need to go back for the questions, meaning if the ones from previous years are in this year's exam.

Yes, many of them are repeated, and of course we reviewed them last year and explained the details. So it's important that you go back to the lectures with this year's lecture. God willing, you won't face any problems with the medicine questions. [Clears throat] We'll start with endocrinology first, and then, God willing, we'll finish with ED.

Okay, first, we'll start with diabetes. Of course, there are things I reviewed last year that focused mostly on oral hypoglycemic medication, which is the management of type 1 and type 2 diabetes. But this year there's a new point that might have repeated questions, which is DKA management. We'll also talk about the diagnosis of diabetes, or when to say a